Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L, Fan Y, Lu H.
Pathol Oncol Res. 2022 Oct 11;28:1610730. doi: 10.3389/pore.2022.1610730. eCollection 2022.
The ovarian stroma as a new frontier.
Kinnear HM, Tomaszewski CE, Chang AL, Moravek MB, Xu M, Padmanabhan V, Shikanov A.
Reproduction. 2020 Sep;160(3):R25-R39. doi: 10.1530/REP-19-0501.
Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1.
Bai M, Jiang N, Fu W, Huang C, Tian L, Mi N, Gao L, Ma H, Lu Y, Cao J, Zhang C, Yue P, Zhang Y, Lin Y, Meng W, Li X.
Hum Cell. 2024 Jan;37(1):364-375. doi: 10.1007/s13577-023-01003-4. Epub 2023 Nov 15.
Hilar cell tumour of the ovary.
Anderson MC.
J Clin Pathol. 1972 Feb;25(2):106-10. doi: 10.1136/jcp.25.2.106.
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses.
Xia T, Li K, Niu N, Shao Y, Ding D, Thomas DL, Jing H, Fujiwara K, Hu H, Osipov A, Yuan C, Wolfgang CL, Thompson ED, Anders RA, He J, Mou Y, Murphy AG, Zheng L.
J Hematol Oncol. 2022 Mar 28;15(1):37. doi: 10.1186/s13045-022-01253-z.
Cholangiocarcinoma--current treatment options.
Friman S.
Scand J Surg. 2011;100(1):30-4. doi: 10.1177/145749691110000106.
Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Sang H, Li T, Li H, Liu J.
PLoS One. 2013 Nov 28;8(11):e81347. doi: 10.1371/journal.pone.0081347. eCollection 2013.
Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.
Tan XY, Chang S, Liu W, Tang HH.
Gut Liver. 2014 Mar;8(2):196-204. doi: 10.5009/gnl.2014.8.2.196. Epub 2013 Nov 5.
T-cell and NK-cell lymphomas in the lung.
Pan Z, Xu ML.
Semin Diagn Pathol. 2020 Nov;37(6):273-282. doi: 10.1053/j.semdp.2020.04.003. Epub 2020 May 16.
Small-cell lung cancer.
Jackman DM, Johnson BE.
Lancet. 2005 Oct 15-21;366(9494):1385-96. doi: 10.1016/S0140-6736(05)67569-1.
